Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. has launched a Phase 1 clinical study titled A Phase 1, ...
Alnylam Pharmaceuticals faces near-term headwinds from TTR franchise momentum concerns. Click here to read why ALNY stock is ...
40/29 News on MSN
Winter virus season so far is not too bad, but doctors worry about suffering to come
A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...
Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...
Exclusive: A majority of Australians want the Federal Government to invest more in the Pharmaceutical Benefits Scheme (PBS) ...
President Donald Trump just announced deals with drugmakers Eli Lilly and Novo Nordisk that will yield lower prices for GLP-1 ...
On December 14, 2020 I became the first person in the United States to receive the first FDA-approved COVID-19 vaccine. Now, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback